+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Therapeutic Plasma Exchange Market by Technology (Centrifugation, Membrane Separation), Indication (Hematologic Disorders, Metabolic Disorders, Neurological Disorders), Product, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5147996
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Therapeutic Plasma Exchange Market size was estimated at USD 792.04 million in 2023, USD 878.53 million in 2024, and is expected to grow at a CAGR of 9.81% to reachUSD 1.52 billion by 2030.

The market includes medical devices, consumables such as replacement fluids, service providers, hospitals, blood centers, and end-users such as patients requiring these treatments. Therapeutic plasma exchange is primarily applied in the treatment of conditions such as Guillain-Barré syndrome, myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis, among others. End-users of this market can be segmented into hospitals, specialized clinics, and outpatient facilities, which are the primary providers of therapeutic plasma exchange therapy. Growth in the market is influenced by factors such as the increasing prevalence of autoimmune diseases, advancements in healthcare infrastructure, supportive healthcare policies, and the increased effectiveness and safety of plasma exchange procedures. Innovations in apheresis technology and the climbing cases of diseases required, paired with the surge in healthcare investments and beneficial reimbursement climates are market major market upscaling trends. However, challenges such as the elevated cost of TPE procedures, lack of awareness in certain demographics, strict regulatory barriers, and competition from alternative treatments may hinder market progression. However, increased healthcare expenditure and education, and the integration of IT to refine treatment accuracy are lucrative opportunities in the market. To foster growth, the sector is poised for breakthroughs in cost-effective device manufacturing, the application of artificial intelligence for treatment optimization, enhanced apheresis material quality, and exploration of new therapeutic plasma exchange applications, heralding a future of innovation and sustained market vitality.

Regional Insights

The global therapeutic plasma exchange (TPE) market showcases variable maturity in the United States and Europe leading in adoption and innovation, regulated strictly by the FDA and EMA respectively. Market relevance is bolstered by the escalating incidence of autoimmune diseases and critical ailments, matched with increasing investments and consumer demand influenced by factors such as insurance coverage and healthcare infrastructure. Developed nations focus on technological advancements to ameliorate TPE, striving to meet high consumer expectations for safety and efficiency. This growth trajectory, however, is balanced by the challenges of cost management, regulatory compliance, and the necessity for professionally trained personnel. Additionally, research is highly collaborative at the EU level, with numerous cross-border initiatives and funding opportunities, such as those provided by the Horizon Europe program, which supports innovation in the healthcare sector.

Emerging markets such as those in Asia, Africa, and parts of the Americas present significant potential due to rising healthcare investments and less stringent regulatory hurdles, indicating a vast untapped patient demographic.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Therapeutic Plasma Exchange Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
  • Technical Advancement in Apheresis Technologies

Market Restraints

  • Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures

Market Opportunities

  • Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
  • Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care

Market Challenges

  • Complications Associated with the Apheresis Procedure in TPE

Market Segmentation Analysis

  • Technology: Membrane separation are preferred selection while therapeutic plasma exchange
  • Indication: Extensive usage of therapeutic plasma exchange for life threatening hematologic disorders
  • Product: Technological advancement in consumables needs should to be compatible with their plasma exchange devices and systems
  • End-user: Blood collection centers & blood component providers are commanding larger user base and support for large scale operative treatments

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Therapeutic Plasma Exchange Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Therapeutic Plasma Exchange Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Dr. Savage Introduces Plasma Exchange for 2024 Weight Loss

A physician at MDLifespan introduced Therapeutic Plasma Exchange that addresses a pivotal element in the battle against obesity, the persistent accumulation of environmental and dietary toxins within the body. By targeting the under-recognized contributors to weight gain and chronic illness, this treatment stands as an active front against the relentless influx of toxins, demonstrating the center’s commitment to enhancing health through innovative modalities.

HealthyLongevity.clinic recently partnered with Dr. Dobri Kiprov

HealthyLongevity.clinic embarked on a pioneering partnership with researcher Dr. Dobri Kiprov to introduce the clinically proven procedure of Therapeutic Plasma Exchange (TPE) to its clientele in Florida. This state-of-the-art therapy, designed to extract and replenish plasma in the body, offers potential benefits for the management and treatment of various medical conditions. The collaboration signifies HealthyLongevity.clinic's commitment to incorporating cutting-edge healthcare solutions, ensuring their patients have access to innovative and effective therapeutic options.

MaxWell Clinic offers Therapeutic Plasma Exchange (TPE) as a Treatment Option for Dementia, Alzheimer's, Memory Los, and Autoimmune Disease

MaxWell Clinic announced the introduction of Therapeutic Plasma Exchange (TPE) for patients grappling with dementia, Alzheimer's, memory loss, and various autoimmune disorders. TPE stands out as a major treatment that meticulously filters out unhealthy toxins, antibodies, and proteins that could potentially impede brain and body functionality. As Alzheimer's and related conditions incur not just extensive financial strains but also prolonged periods of emotional distress for patients and their loved ones, conventional medications largely address only symptomatic relief without halting disease progression.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Therapeutic Plasma Exchange Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Plasma Exchange Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Bio Products Laboratory Ltd., Cerus Corporation, Charles River Laboratories International, Inc., CSL Behring, Elastrin Therapeutics, Inc., Fresenius Medical Care AG & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Infomed SA, Kaneka Corporation, Kedrion Biopharma Inc., Mallinckrodt PLC, Medica S.P.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., Pall Corporation, Plasma Technologies, LLC, Qingdao Haier Biomedical Co., Ltd, Sb-Kawasumi Laboratories, Inc., and Terumo BCT, Inc..

Market Segmentation & Coverage

This research report categorizes the Therapeutic Plasma Exchange Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology

  • Centrifugation
  • Membrane Separation
  • Indication

Hematologic Disorders

  • Atypical Hemolytic Uremic Syndrome
  • Hyperviscosity Syndrome
  • Severe/Symptomatic Cryoglobulinemia
  • Thrombotic Thrombocytopenic Purpura
  • Metabolic Disorders

Neurological Disorders

  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Guillain-Barré Syndrome
  • Multiple Sclerosis
  • Myasthenia Gravis
  • PANDAS

Renal Disorders

  • Antibody-mediated Renal Transplant Rejection
  • Goodpasture Syndrome
  • Wegener's Granulomatosis

Product

  • Consumables
  • Devices

End-user

  • Blood Collection Centers & Blood Component Providers
  • Hospitals & Transfusion Centers

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need of Therapeutic Plasma Exchange due to Rise in Prevalence of Autoimmune and Cardiac Diseases
5.1.1.2. Technical Advancement in Apheresis Technologies
5.1.2. Restraints
5.1.2.1. Cost Associated with the Devices and Therapeutic Plasma Exchange Procedures
5.1.3. Opportunities
5.1.3.1. Advancement in Therapeutic Plasma Exchange Technology and its Immunomodulatory Effect in Neuromuscular Diseases
5.1.3.2. Surge in Demand for Therapeutic Plasma Exchange (TPE) in Pediatric Intensive Care
5.1.4. Challenges
5.1.4.1. Complications Associated with the Apheresis Procedure in TPE
5.2. Market Segmentation Analysis
5.2.1. Technology: Membrane separation are preferred selection while therapeutic plasma exchange
5.2.2. Indication: Extensive usage of therapeutic plasma exchange for life threatening hematologic disorders
5.2.3. Product: Technological advancement in consumables needs should to be compatible with their plasma exchange devices and systems
5.2.4. End-user: Blood collection centers & blood component providers are commanding larger user base and support for large scale operative treatments
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Therapeutic Plasma Exchange Market, by Technology
6.1. Introduction
6.2. Centrifugation
6.3. Membrane Separation
7. Therapeutic Plasma Exchange Market, by Indication
7.1. Introduction
7.2. Hematologic Disorders
7.3. Metabolic Disorders
7.4. Neurological Disorders
7.5. Renal Disorders
8. Therapeutic Plasma Exchange Market, by Product
8.1. Introduction
8.2. Consumables
8.3. Devices
9. Therapeutic Plasma Exchange Market, by End-user
9.1. Introduction
9.2. Blood Collection Centers & Blood Component Providers
9.3. Hospitals & Transfusion Centers
10. Americas Therapeutic Plasma Exchange Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Therapeutic Plasma Exchange Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Therapeutic Plasma Exchange Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Dr. Savage Introduces Plasma Exchange for 2024 Weight Loss
13.3.2. HealthyLongevity.clinic recently partnered with Dr. Dobri Kiprov
13.3.3. MaxWell Clinic offers Therapeutic Plasma Exchange (TPE) as a Treatment Option for Dementia, Alzheimer's, Memory Los, and Autoimmune Disease
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. THERAPEUTIC PLASMA EXCHANGE MARKET RESEARCH PROCESS
FIGURE 2. THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THERAPEUTIC PLASMA EXCHANGE MARKET DYNAMICS
FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. THERAPEUTIC PLASMA EXCHANGE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. THERAPEUTIC PLASMA EXCHANGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE SEPARATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ATYPICAL HEMOLYTIC UREMIC SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HYPERVISCOSITY SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SEVERE/SYMPTOMATIC CRYOGLOBULINEMIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY THROMBOTIC THROMBOCYTOPENIC PURPURA, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PANDAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTIBODY-MEDIATED RENAL TRANSPLANT REJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GOODPASTURE SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY WEGENER'S GRANULOMATOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 71. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 72. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 73. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 74. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 86. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 87. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 88. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 89. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 90. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 100. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 101. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 102. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 103. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 104. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 110. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 111. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 112. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 113. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 114. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 115. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 116. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 117. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 118. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 119. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 122. CANADA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 123. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 128. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 129. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 130. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 131. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 132. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 133. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 134. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 135. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. MEXICO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 143. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 144. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 145. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 146. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 160. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 162. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 174. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 175. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 176. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 177. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 178. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 184. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 185. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 186. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 187. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 188. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 189. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 190. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 191. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 192. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 193. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 200. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 201. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 202. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 203. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 204. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 205. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 206. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 207. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. INDIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 216. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 217. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 218. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 219. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 220. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 226. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 227. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 228. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 229. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 230. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 231. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 232. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 233. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 234. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 235. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 238. JAPAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 243. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 244. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 245. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 246. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 247. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 248. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 258. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 259. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 260. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 261. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 262. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 271. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 272. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 273. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 274. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 275. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 276. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 285. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 286. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 287. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 288. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 289. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 290. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 299. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2018-2023 (USD MILLION)
TABLE 300. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGIC DISORDERS, 2024-2030 (USD MILLION)
TABLE 301. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 302. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 303. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2018-2023 (USD MILLION)
TABLE 304. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 310. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 311. THAILAND THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. THAILAND THERAPEUTIC PL

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bio Products Laboratory Ltd.
  • Cerus Corporation
  • Charles River Laboratories International, Inc.
  • CSL Behring
  • Elastrin Therapeutics, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Infomed SA
  • Kaneka Corporation
  • Kedrion Biopharma Inc.
  • Mallinckrodt PLC
  • Medica S.P.A.
  • Medicap Clinic GmbH
  • MEISE Medizintechnik GmbH
  • Miltenyi Biotec
  • Nikkiso Co., Ltd.
  • Pall Corporation
  • Plasma Technologies, LLC
  • Qingdao Haier Biomedical Co., Ltd
  • Sb-Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 878.53 Million
Forecasted Market Value ( USD ) by 2030 $ 1525.84 Million
Compound Annual Growth Rate9.8%
Regions CoveredGlobal

Related Topics

Related Reports

Therapeutic Plasma Exchange - Global Strategic Business Report - Product Image

Therapeutic Plasma Exchange - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Therapeutic Plasma Exchange Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Therapeutic Plasma Exchange Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 188 Pages
  • Global
From
Global Therapeutic Plasma Exchange Market Report 2024 - Product Image

Global Therapeutic Plasma Exchange Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Therapeutic Plasma Exchange Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Therapeutic Plasma Exchange Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 93 Pages
  • Global
From
Apheresis Equipment - Global Strategic Business Report - Product Image

Apheresis Equipment - Global Strategic Business Report

  • Report
  • 604 Pages
  • Global
From

About the Therapeutic Plasma Exchange Market

Therapeutic Plasma Exchange (TPE) is a process used in blood banking to treat a variety of medical conditions. It involves the removal of plasma from a patient's blood and replacing it with donor plasma or a plasma substitute. The process is used to treat conditions such as autoimmune diseases, thrombotic thrombocytopenic purpura, and hemolytic anemia. It is also used to remove antibodies and other substances from the blood that can cause adverse reactions. TPE is a specialized procedure that requires specialized equipment and trained personnel. It is typically performed in a hospital or clinic setting. The process is usually done in a series of treatments, with the number of treatments depending on the condition being treated. The TPE market is a growing segment of the blood banking industry. It is a highly specialized field that requires specialized equipment and personnel. Companies in the market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Asahi Kasei Medical. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.